Why Metacrine's Stock Is Trading Higher Today

Metacrine MTCR shares are trading higher on Monday after multiple firms initiated coverage on the stock with a bullish rating.

Metacrine is a clinical-stage biopharmaceutical company focused on discovering and developing differentiated therapies for patients with liver and gastrointestinal diseases.

Metacrine shares traded up 6.83% to $10.86 on Monday at the time of publication. The stock has a 52-week high of $16.19 and a 52-week low of $9.06.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: InitiationAnalyst Ratingswhy it's moving
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!